Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 21, 2021; 27(35): 5967-5977
Published online Sep 21, 2021. doi: 10.3748/wjg.v27.i35.5967
Published online Sep 21, 2021. doi: 10.3748/wjg.v27.i35.5967
Table 3 Immunohistochemical features of the 26 cases of hepatic PEComa
| Target protein | Positive cases (n)/total | % Positive |
| HMB45 | 25/26 | 96.2 |
| Melan-A | 23/26 | 88.5 |
| SMA | 22/26 | 83.6 |
| Desmin | 1/26* | 3.8 |
| S100 | 14/26 | 53.8 |
| Hepatocyte | 9/26 | 34.6 |
| Vimentin | 20/26 | 76.9 |
| CD34 | 18/26 | 69.2 |
| TFE3 | 0/26 | 0 |
| Ki-67 (> 10%) | 1/26 | 3.8 |
- Citation: Zhang S, Yang PP, Huang YC, Chen HC, Chen DL, Yan WT, Yang NN, Li Y, Li N, Feng ZZ. Hepatic perivascular epithelioid cell tumor: Clinicopathological analysis of 26 cases with emphasis on disease management and prognosis. World J Gastroenterol 2021; 27(35): 5967-5977
- URL: https://www.wjgnet.com/1007-9327/full/v27/i35/5967.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i35.5967